Bijal D. Shah, MD

BOARD CERTIFICATION:
          •  Hematology
          •  Pediatrics
          •  Medical Oncology

FELLOWSHIP:
          •  Moffitt Cancer Center - Hematology & Oncology

RESIDENCY:
          •  Duke University - Internal Medicine & Pediatrics

MEDICAL SCHOOL:
          •  University of South Florida - MD

• Martin P, Shah B. Limited-stage mantle cell lymphoma: not so different from advanced-stage. Leuk Lymphoma. 2013 Feb;54(2):217-218. Pubmedid: 22988842.


• Cheng F, Wang H, Horna P, Wang Z, Shah B, Sahakian E, Woan KV, Villagra A, Pinilla-Ibarz J, Sebti S, Smith M, Tao J, Sotomayor EM. Stat3 Inhibition Augments the Immunogenicity of B-cell Lymphoma Cells, Leading to Effective Antitumor Immunity. Cancer Res. 2012 Sep;72(17):4440-4448. Pubmedid: 22728650.


• Shah BD, Martin P, Sotomayor EM. Mantle cell lymphoma: a clinically heterogeneous disease in need of tailored approaches. Cancer Control. 2012 Jul;19(3):227-235. Pubmedid: 22710898.


• Trimaldi J, Carballido EM, Bowers JW, Anguiano AL, Zhang ZJ, Shah BD, Bruno S, List AF, Moscinski LC, Grady T, Agosti SJ, Kang L, Zhang L. B-Lymphoblastic Leukemia/Lymphoma Associated with t(8;13)(p11;q12)/ ZMYM2 (ZNF198)-FGFR1 : Rare Case and Review of the Literature. Acta Haematol. 2013 Apr;130(3):127-134. Pubmedid: 23594707.

Dr. Shah's primary clinical interests are in non-Hodgkin lymphomas (particularly Mantle Cell Lymphoma) and acute leukemias (particularly acute lymphoblastic leukemia). As an internist and pediatrician, Dr. Shah also has a special interest in adolescent and young adult malignant hematology.